Details
Stereochemistry | UNKNOWN |
Molecular Formula | C21H29NO.ClH |
Molecular Weight | 347.922 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.OC(CCN1CCCCC1)(C2CC3CC2C=C3)C4=CC=CC=C4
InChI
InChIKey=RDNLAULGBSQZMP-UHFFFAOYSA-N
InChI=1S/C21H29NO.ClH/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17;/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C21H29NO |
Molecular Weight | 311.4611 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:43:24 UTC 2023
by
admin
on
Fri Dec 15 15:43:24 UTC 2023
|
Record UNII |
K35N76CUHF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C38149
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
||
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000090297
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
SUB00807MIG
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
91154
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | RxNorm | ||
|
K35N76CUHF
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
84989
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
DBSALT000804
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
BIPERIDEN HYDROCHLORIDE
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | Description: A white, crystalline powder; odourless. Solubility: Slightly soluble in water, ethanol (~750 g/l) TS and ether R; sparingly soluble in methanol R. Category: Antiparkinsonism drug. Storage: Biperiden hydrochloride should be kept in a well-closed container, protected from light. Definition: Biperiden hydrochloride contains not less than 98.0% and not more than 101.0% of C21H29NO,HCl, calculated with reference to the dried substance. | ||
|
170950
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
59171
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
92151
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
C65264
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
DTXSID2047856
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
m2508
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | Merck Index | ||
|
1235-82-1
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
CHEMBL1101
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY | |||
|
214-976-2
Created by
admin on Fri Dec 15 15:43:25 UTC 2023 , Edited by admin on Fri Dec 15 15:43:25 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
http://apps.who.int/phint/pdf/b/Jb.6.1.59.pdf
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
Maximum 0.50 per cent of the area of the principal peak
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
Maximum 0.50 per cent of the area of the principal peak
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
Maximum 0.50 per cent of the area of the principal peak
CHROMATOGRAPHIC PURITY (GC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |